BioSpace News Archive

Policy

Order in the Court: Novo Nordisk, Eli Lilly & BMS Face Legal Battles

Novo Nordisk and Eli Lilly came under legal scrutiny this week, while BMS forked over $11 million to settle claims over anticompetitive tactics.

June 8, 2022
·
3 min read
·
Alex Keown
Researchers Report Gene Therapy May Correct Creatine Deficiency Disorder

UCLA researchers report gene therapy may correct a rare creatine deficiency disorder that results in intellectual disabilities, issues with speech, involuntary movements and recurrent seizures.

June 8, 2022
·
2 min read
·
Jazmine Colatriano
Drug Development

AstraZeneca’s Evusheld Successfully Prevents Progression to Severe COVID-19

Results of the Phase III trial showed that Evusheld protected against progression to severe COVID-19 or death in the early outpatient treatment of mild-to-moderate COVID-19.

June 8, 2022
·
3 min read
·
Hannah Chudleigh
Business

Actor Greg Grunberg Discusses New Series: “The Care Giver”

Greg Grunberg, who has appeared in multiple Star Wars projects, has partnered with Jazz Pharmaceuticals to bring “The Care Giver”, a video web series, to life.

June 8, 2022
·
4 min read
·
Alex Keown
Drug Development

Global Roundup: Denmark’s Ascendis Sees “Real Control” in Hypothyroidism

At ENDO 2022, Ascendis will share Phase II and III data showing clinical efficacy for its investigational product candidate for hypoparathyroidism. For this and more, see inside.

June 8, 2022
·
7 min read
·
Alex Keown
Drug Development

Disparate Geographical Data from Rigel Anemia Trial “Confound” Investigator

South San Francisco-based Rigel Pharmaceuticals reported its Phase III Forward trial of fostamatinib did not show statistical significance in warm autoimmune hemolytic anemia

June 8, 2022
·
3 min read
·
Mark Terry
Business

Astellas Makes Big Commitment to Gene Therapy with New NC Facility

The new space will enable Astellas to establish a global supply chain of gene therapies as well as widen the scope of the therapeutic products it creates.

June 8, 2022
·
3 min read
·
Hannah Chudleigh
Drug Development

Mineralys Therapeutics Rakes in $118M for Hypertension Therapy

Mineralys Therapeutics, a clinical-stage biopharmaceutical company focused on developing a best-in-class, novel therapy for high blood pressure, closed a $118 million Series B investment round.

June 8, 2022
·
2 min read
·
Paolo Besabella
Business

Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the PDUFA Target Action Date for ACER-001

RELIEF THERAPEUTICS Holding SA reported that its collaboration partner, Acer Therapeutics, Inc., announced that it has not yet received a decision from the U.S. Food and Drug Administration on its 505 New Drug Application for ACER-001, for the treatment of urea cycle disorders.

June 8, 2022
·
3 min read
Medical Equipment Rental Market Outlook 2028, Global Opportunity & Growth Analysis

Wilmington, Delaware, United States: According to the report, the global medical equipment rental market was valued at US$ 51.05 Bn in 2020.

June 8, 2022
·
7 min read